Table 11 Pooled means of the distribution of crude mortality and crude excess mortality of adult and paediatric intensive care unit patients with and without device-associated healthcare-acquired infection
Adult and paediatric ICUs combined | No. of deaths | No. of patients | Pooled crude mortality, % (95% CI) | RR (95% CI) |
|---|---|---|---|---|
Crude mortality of patients without DA-HAI | 1,616 | 6,408 | 25.2 (24.1- 26.3) | 1.0 |
Crude mortality of patients with CLABSI | 133 | 357 | 37.3 (32.2- 42.4) | 1.5 (1.2 – 1.8) |
Crude excess mortality of patients with CLABSI | 133 | 357 | 12.0 (8.1- 16.1) | - |
Crude mortality of patients with CAUTI | 55 | 154 | 35.7 (28.1- 43.8) | 1.4 (1.1 – 1.9) |
Crude excess mortality of patients with CAUTI | 55 | 154 | 10.5 (4.0- 17.5) | - |
Crude mortality of patients with VAP | 253 | 567 | 44.6 (40.4- 48.8) | 1.8 (1.6 – 2.0) |
Crude excess mortality of patients with VAP | 253 | 567 | 19.4 (16.3- 22.5) | - |
Neonatal ICUs combined | No. of deaths | No. of patients | Pooled crude mortality, % (95% CI) | |
Crude mortality of patients without DA-HAI | 68 | 1,964 | 3.5 (2.7- 4.4) | 1.0 |
Crude mortality of patients with CLABSI | 10 | 53 | 18.9 (9.4- 32.7) | 5.5 (2.8 – 10.6) |
Crude excess mortality of patients with CLABSI | 10 | 53 | 15.4 (6.7- 28.3) | - |
Crude mortality of patients with VAP | 6 | 43 | 14.0 (5.3- 27.9) | 4.0 (1.8 – 9.3) |
Crude excess mortality of patients with VAP | 6 | 43 | 10.5 (2.6- 23.5) | - |